Johnson & Johnson's DePuy orthopedics business plans to stop selling a couple of hip replacement systems not widely used by doctors. DePuy will discontinue both its Ultamet Metal-on-Metal Articulation and Complete Ceramic-on-Metal Acetabular systems worldwide at the end of August.
The agency said Monday that Bard will pay $48.3 million to resolve allegations that its actions resulted in false claims made to Medicare, and the company will pay another $2.2 million as part of a non-prosecution agreement. The agency says the kickbacks were paid between 1998 and 2006.
Researchers at Weill Cornell Medical College have successfully tested their novel anti-cocaine vaccine in primates, bringing them closer to launching human clinical trials. Their study, published online by the journal Neuropsychopharmacology, used a radiological technique to demonstrate that the anti-cocaine vaccine prevented the drug from reaching the brain and producing a dopamine-induced high.
Licensed practice is commonplace or mandatory in other fields, particularly construction, medicine and law, so should those individuals handily responsible for most every article we use every day also be given greater accountability for the science they practice?
Still at least a year away from the market, the 27-pound Indego is the lightest of the powered exoskeletons. It snaps together from pieces that fit into a backpack. The goal is for the user to be able to carry it on a wheelchair, put it together, strap it on and walk independently.
Medical device maker NuVasive Inc. said Monday it acquired ANC LLC, one of the key suppliers of its spinal implants, for $4.5 million. NuVasive said the companies have worked together since May 2010. NuVasive wants to handle more of its own manufacturing so it can improve its profitability. It said the acquisition won't affect its net income in 2013.
The technology indicates how rapidly the field of prosthetics is changing, benefiting patients from injured military members to victims of the Boston Marathon bombing. Practitioners say increased government research in the wake of the wars in Iraq and Afghanistan is driving some of the advances.
After attending the Marcus Evans Group’s 7th Annual OI Summit, I was delighted to see the evolution currently happening in the OI stratosphere. I was privy to a few surprises in the lineup from non-traditional players in the OI space, making this dynamic open innovations platform technologically enticing.
CareFusion Corp. said Thursday it will pay about $41 million to resolve a government investigation into marketing practices for its antiseptic ChloraPrep. The investigation also covered CareFusion's relationships with health care professionals. The company said it agreed to the settlement in principle and is also entering into a non-prosecution agreement.
The jury in federal court in Louisville awarded $6.25 million in punitive damages and $994,000 in compensatory damages on Wednesday to the family of Breanna Sadler of Vine Grove. Sadler's family sued Advanced Bionics in 2011 — about three years after the girls' cochlear implant made her ill.
The bionic legs he uses cost $60,000 a piece, are hydraulically operated and equipped with microchips and a gyroscope that sense when to relax and stiffen to help him walk. Walter Reed was involved in developing the legs, said Zach Harvey, former prosthetics chief at Walter Reed.
Hundreds of women who received faulty breast implants gathered Wednesday in a makeshift courthouse in the south of France for the fraud trial of five executives accused of using cheap industrial silicone to fill tens of thousands of implants that were sold around the world.
The Supreme Court grapples Monday with the question of whether human genes can be patented, and the ultimate answer could reshape U.S. medical research, the fight against diseases like breast and ovarian cancer and the multi-billion dollar medical and biotechnology business.
Abbott Laboratories is recalling its FreeStyle InsuLinx Blood Glucose Meters after finding that they display and store incorrect test results for dangerously high blood sugar levels. The company says the meters will display and store readings for blood glucose levels of 1,024 milligrams per deciliter or higher at much lower levels.
The company said it is taking some production lots of its DuraGen and Dural Graft Matrix products off the market because of possible "deviations from approved manufacturing processes." The products were made at a facility in Añasco, Puerto Rico, between December 2010 and May 2011 and between November 2012 and March 2013.
The high-tech helper is under scrutiny over reports of problems, including several deaths that may be linked with it and the high cost of using the robotic system. There also have been a few disturbing, freak incidents: a robotic hand that wouldn't let go of tissue grasped during surgery and a robotic arm hitting a patient in the face.
A federal appeals court says that a Johnson & Johnson heart stent does not infringe a patent held by a doctor and inventor, overturning a $482 million decision against the company. The three-judge panel said a lower court misinterpreted the company's patent and should not have ruled in favor of Bruce Saffran, a doctor from Princeton, N.J.
Sony Corp. and Olympus Corp. said Wednesday they will merge their medical businesses on April 16, after it was postponed twice due to a delay in obtaining regulatory approval overseas. The two companies initially planned to set up the new medical equipment company, to be named Sony Olympus Medical Solutions Inc., by the end of last year.
A researcher at the Medical College of Wisconsin is charged with espionage after prosecutors say he stole details of a cancer-fighting compound that he wanted to share with China. Prosecutors say Hua Jun Zhao stole the compound, C-25, and data that led to its development.
India's Supreme Court on Monday rejected drug maker Novartis AG's attempt to patent an updated version of a cancer drug in a landmark decision that health activists say ensures poor patients around the world will get continued access to cheap versions of lifesaving medicines.
The Department of Health and Human Services' inspector general said the increasingly common practice is "inherently suspect" and may violate anti-kickback laws, according to the special fraud alert. The agency has only issued a handful of these national fraud alerts in the past 20 years and the warning sends a strong message to doctors.
Brown University has signed a deal with Lifespan to market biomedical discoveries and inventions by researchers in the state's largest health system. The university said Monday that its Technology Ventures Office will help manage and provide marketing, licensing, business development and other services for certain new discoveries made by Lifespan scientists.
Johnson & Johnson has announced a voluntary recall for all its OneTouch VerioIQ blood glucose meters in the U.S. because they do not provide a warning when a diabetic's blood sugar level is dangerously high. Instead, the meters turn off. The meters are made by J&J's LifeScan unit, which will issue a free replacement meter to all patients.
Heart care is in the midst of a transformation. Many problems that once required sawing through the breastbone and opening up the chest for open heart surgery now can be treated with a nip, twist or patch through a tube. These minimal procedures used to be done just to unclog arteries and correct less common heart rhythm problems.
The Supreme Court will soon decide whether generic drug manufacturers can be sued in state court for a drug's design defects after federal officials approved the brand-name version. The justices Tuesday heard arguments from generic manufacturer Mutual Pharmaceutical Co, Inc.